Mayo team spotlights the role of senescent cells in neurodegeneration, starting down a pathway that may lead to Alzheimer’s
As anti-aging research grows around the world, there’s been a big focus on clearing away the “senescent” cells that clutter bodies as people grow older. These aging cells lose the ability to divide and mouse studies have offered a preclinical theory that sweeping them away with new drugs can offer people longer, healthier lives.
Now a research team at the Mayo Clinic is offering more animal data to back that up, and they’re shining a light on a new pathway in neurodegeneration and specifically Parkinson’s and Alzheimer’s — perhaps the single most frustrating field in drug development.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.